Growth Metrics

Vivos (RDGL) Shareholder's Equity Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Vivos - - -3,105.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -22.65%
Sep 30, 2025 82.56%
Jun 30, 2025 67.12%
Mar 31, 2025 143.70%
Dec 31, 2024 57.29%
Sep 30, 2024 -18.07%
Jun 30, 2024 -4.40%
Mar 31, 2024 -7.44%
Dec 31, 2023 -17.82%
Sep 30, 2023 -22.60%
Jun 30, 2023 87.77%
Mar 31, 2023 15.57%
Dec 31, 2022 13.20%
Sep 30, 2022 32.35%
Jun 30, 2022 -45.06%
Mar 31, 2022 -33.27%
Dec 31, 2021 4,480.70%
Sep 30, 2021 263.68%
Jun 30, 2021 307.17%
Mar 31, 2021 246.47%
Dec 31, 2020 102.16%
Sep 30, 2020 27.06%
Jun 30, 2020 36.29%
Mar 31, 2020 -19.55%
Dec 31, 2019 -57.05%
Sep 30, 2019 96.56%
Jun 30, 2019 88.46%
Mar 31, 2019 79.44%
Dec 31, 2018 77.90%
Sep 30, 2018 -879.25%
Jun 30, 2018 29.54%
Mar 31, 2018 65.96%
Dec 31, 2017 -41.13%
Sep 30, 2017 83.85%
Jun 30, 2017 33.58%
Mar 31, 2017 24.07%
Dec 31, 2016 78.93%
Sep 30, 2016 -150.11%
Jun 30, 2016 -46.35%
Mar 31, 2016 7.03%
Dec 31, 2015 28.92%
Sep 30, 2015 7.04%
Jun 30, 2015 -61.02%
Mar 31, 2015 -126.80%
Dec 31, 2014 -124.89%
Sep 30, 2014 -11.23%
Jun 30, 2014 -19.94%
Mar 31, 2014 -12.73%
Dec 31, 2013 8.99%
Sep 30, 2013 -44.29%
Jun 30, 2013 -30.17%
Mar 31, 2013 -51.43%
Dec 31, 2012 -103.70%
Sep 30, 2012 -40.27%
Jun 30, 2012 -58.56%
Dec 31, 2011 -63.12%